Total Payments
$2,090
2024 Payments
$1,233
Companies
11
Transactions
14
Medicare Patients
2,470
Medicare Billing
$41,648
Payment Breakdown by Category
Consulting$1,031 (49.3%)
Food & Beverage$851.43 (40.7%)
Education$207.25 (9.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,031 | 2 | 49.3% |
| Food and Beverage | $851.43 | 9 | 40.7% |
| Education | $207.25 | 3 | 9.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BeiGene USA, Inc. | $900.00 | 1 | $0 (2024) |
| ABBVIE INC. | $248.49 | 2 | $0 (2024) |
| PFIZER INC. | $220.36 | 2 | $0 (2024) |
| Seagen Inc. | $131.03 | 2 | $0 (2023) |
| Genentech USA, Inc. | $125.00 | 1 | $0 (2023) |
| Adaptive Biotechnologies Corporation | $116.93 | 1 | $0 (2022) |
| Amgen Inc. | $102.50 | 1 | $0 (2024) |
| Kite Pharma, Inc. | $99.52 | 1 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $84.75 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $37.85 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,233 | 4 | BeiGene USA, Inc. ($900.00) |
| 2023 | $685.26 | 7 | Genentech USA, Inc. ($125.00) |
| 2022 | $154.78 | 2 | Adaptive Biotechnologies Corporation ($116.93) |
| 2021 | $17.14 | 1 | Seagen Inc. ($17.14) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $102.50 | General |
| 07/23/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $131.25 | General |
| 03/23/2024 | PFIZER INC. | — | Education | In-kind items and services | $99.00 | General |
| 11/07/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $113.89 | General |
| Category: Oncology | ||||||
| 10/17/2023 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $99.52 | General |
| Category: CELLT | ||||||
| 10/13/2023 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Education | In-kind items and services | $23.50 | General |
| Category: Monoclonal Antibody | ||||||
| 08/28/2023 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $117.24 | General |
| Category: ONCOLOGY | ||||||
| 03/24/2023 | SANOFI-AVENTIS U.S. LLC | ELITEK (Biological) | Education | In-kind items and services | $84.75 | General |
| Category: Oncology | ||||||
| 02/23/2023 | Genentech USA, Inc. | Lunsumio (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: BioOncology | ||||||
| 09/27/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $37.85 | General |
| 03/31/2022 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | In-kind items and services | $116.93 | General |
| Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | ||||||
| 11/18/2021 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,013 | 1,776 | $78,247 | $20,339 |
| 2022 | 16 | 818 | 1,364 | $59,574 | $13,906 |
| 2021 | 11 | 340 | 470 | $10,562 | $4,199 |
| 2020 | 6 | 299 | 432 | $5,224 | $3,204 |
Total Patients
2,470
Total Services
4,042
Medicare Billing
$41,648
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 41 | 55 | $22,770 | $3,018 | 13.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 117 | 224 | $6,272 | $2,300 | 36.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 122 | 288 | $8,352 | $2,184 | 26.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 108 | 222 | $2,220 | $1,856 | 83.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 15 | 22 | $7,700 | $1,760 | 22.9% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 31 | 126 | $3,780 | $1,121 | 29.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 45 | 62 | $2,790 | $901.58 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $3,300 | $883.30 | 26.8% |
| 82746 | Folic acid level, serum | Office | 2023 | 44 | 61 | $2,745 | $864.60 | 31.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 44 | 63 | $3,150 | $841.68 | 26.7% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 80 | 117 | $1,989 | $686.72 | 34.5% |
| 84100 | Phosphate level | Office | 2023 | 82 | 118 | $1,534 | $544.05 | 35.5% |
| 83550 | Iron binding capacity | Office | 2023 | 44 | 62 | $1,550 | $531.34 | 34.3% |
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2023 | 22 | 26 | $1,560 | $530.14 | 34.0% |
| 84550 | Uric acid level, blood | Office | 2023 | 80 | 117 | $1,638 | $513.88 | 31.4% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 15 | 28 | $2,380 | $502.66 | 21.1% |
| 83540 | Iron level | Office | 2023 | 44 | 62 | $1,550 | $393.08 | 25.4% |
| 83735 | Magnesium level | Office | 2023 | 19 | 48 | $864.00 | $315.36 | 36.5% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 12 | 15 | $825.00 | $278.70 | 33.8% |
| 85046 | Red blood count automated, with additional calculations | Office | 2023 | 25 | 33 | $528.00 | $180.18 | 34.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 15 | $750.00 | $133.05 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 32 | 38 | $15,732 | $2,309 | 14.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 114 | 192 | $5,359 | $1,989 | 37.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 119 | 246 | $5,426 | $1,875 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 15 | $13,605 | $1,390 | 10.2% |
About Kristel Howell, ARNP
Kristel Howell, ARNP is a Acute Care healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2011. The National Provider Identifier (NPI) number assigned to this provider is 1326344789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kristel Howell, ARNP has received a total of $2,090 in payments from pharmaceutical and medical device companies, with $1,233 received in 2024. These payments were reported across 14 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($1,031).
As a Medicare-enrolled provider, Howell has provided services to 2,470 Medicare beneficiaries, totaling 4,042 services with total Medicare billing of $41,648. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Des Moines, IA
- Active Since 02/02/2011
- Last Updated 11/18/2025
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1326344789
Products in Payments
- BRUKINSA (Drug) $900.00
- Lunsumio (Biological) $125.00
- ELREXFIO (Drug) $121.36
- EPKINLY (Drug) $117.24
- clonoSEQ (Device) $116.93
- ADCETRIS (Biological) $113.89
- Yescarta (Drug) $99.52
- ELITEK (Biological) $84.75
- Poteligeo (Drug) $23.50
- TUKYSA (Drug) $17.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Des Moines
Michele Renze, Arnp, ARNP
Acute Care — Payments: $3,201
Acute Care $3,201
Samantha Bonin, Dnp, Agacnp-Bc, DNP, AGACNP-BC
Acute Care — Payments: $2,354
Acute Care $2,354
Julie Schuck, A.r.n.p, A.R.N.P
Acute Care — Payments: $1,357
Acute Care $1,357
Julie Shryock, Dnp, DNP
Acute Care — Payments: $1,124
Acute Care $1,124
Gloria Miller, Arnp, ARNP
Acute Care — Payments: $797.34
Acute Care $797.34
Elizabeth Biggerstaff, Arnp, ARNP
Acute Care — Payments: $686.35
Acute Care $686.35